1.6 Contingent liabilities and Contingent
Assets

A contingent liability is a possible obligation that arises
from past events whose existence will be confirmed by the
occurrence or non-occurrence of one or more uncertain
future events beyond the control of the company or a
present obligation that is not recognised because it is not
probable that an outflow of resources will be required to
settle the obligation. A contingent liability also arises in
extremely rare cases where there is a liability that cannot
be recognised because it cannot be measured reliably. The
contingent liability is not recognised in books of account but
its existence is disclosed in financial statements.

Contingent liabilities are disclosed when there is a possible
obligation arising from past events, the existence of which
will be confirmed only by the occurrence or non-occurrence
of one or more uncertain future events not wholly within the
control of the Company or a present obligation that arises
from past events where it is either not probable that an
outflow of resources will be required to settle the obligation
or a reliable estimate of the amount cannot be made.

A contingent asset is a possible asset that arises from
past events and whose existence will be confirmed only
by future events not wholly within the control of the entity.
Contingent assets require disclosure only. If the realisation
of income is virtually certain, the related asset is not a
contingent asset and recognition is require.

1.7 Impairment of non-financial assets

The Company assesses, at each reporting date, whether
there is an indication that an asset may be impaired. If
any indication exists, or when annual impairment testing
for an asset is required, the Company estimates the asset's
recoverable amount. An asset's recoverable amount is the
higher of an asset's or cash-generating unit's (CGU) fair
value less costs of disposal and its value in use. Recoverable
amount is determined for an individual asset. unless the
asset does not generate cash inflows that are largely
independent of those from other assets or Company's assets.
When the carrying amount of an asset or CGU exceeds its
recoverable amount, the asset is considered impaired and
is written down to its recoverable amount.

A previously recognised impairment loss is further provided
or reversed depending on changes in the circumstances and
to the extent that carrying amount of the assets does not

exceed the carrying amount that will be determined if no
impairment loss had previously been recognised.

1.8 Provisions

Provisions are recognised when the Company has a present
obligation (legal or constructive) as a result of a past event,
it is probable that an outflow of resources embodying
economic benefits will be required to settle the obligation
and a reliable estimate can be made of the amount of the
obligation. When the Company expects some or all of a
provision to be reimbursed the reimbursement is recognised
as a separate asset, but only when the reimbursement is
virtually certain. The expense relating to a provision
is presented in the statement of profit and loss net of
any reimbursement.

If the effect of the time value of money is material, provisions
are discounted using a current pre-tax rate that reflects,
when appropriate, the risks specific to the liability. When
discounting is used, the increase in the provision due to the
passage of time is recognised as a finance cost.

1.9 a) Property, plant and equipment

Property, plant and equipment are stated at cost net
of accumulated depreciation and where applicable
accumulated impairment losses. Property, plant
and equipment and capital work in progress cost
include expenditure that is directly attributable to the
acquisition of the asset. The cost of self-constructed
assets includes the cost of materials, direct labour
and any other costs directly attributable to bringing
the asset to a working condition for its intended use,
and the costs of dismantling and removing the items
and restoring the site on which they are located.
Purchased software that is integral to the functionality
of the related equipment is capitalized as part of
that equipment.

When parts of an item of proper t y, plant and
equipment have different useful lives, they are
accounted for as separate items (major components)
of property, plant and equipment.

Property, plant and equipment that are not ready for
intended use as on the date of Standalone Balance
Sheet are disclosed as 'capital work-in-progress'.

Subsequent Cost

The cost of replacing part of an item of property, plant
and equipment is recognised in the carrying amount
of the item if it is probable that the future economic
benefits embodied within the part will flow to the
Company and its cost can be measured reliably. The
carrying amount of the replaced part is de-recognised
and charged to the statement of Profit and Loss. The
costs of the day-to-day servicing of property, plant
and equipment are recognised in the Statement of
Profit and Loss.

b) Intangible assets

Intangible assets are stated at cost less
accumulated amortisation and impairment loss.
The system software which is expected to provide
future enduring benefits is capitalised. The capitalised
cost includes license fees and cost of implementation/
system integration. Computer software cost is
amortised over a period of three years using the
straight-line method.

Development expenditure qualifying as an intangible
asset, if any, is capitalised, to be amortised over the
economic life of the product/patent.

Depreciation and amortisation

The charge in respect of periodic depreciation is
derived after determining an estimate of expected
useful life and the expected residual value of the
assets at the end of its useful life. The lives are based
on historical experience with similar assets as well
as anticipation of future events, which may impact
their life.

The depreciation on tangible assets is calculated on
SLM method over the estimated useful life of assets
prescribed by the Schedule II to the Companies Act
2013 as follows:

The useful life has been determined based on technical
evaluation done by the Management/experts, which
are different from the useful life prescribed in Part C of
Schedule II of the Act in order to reflect actual use of
the assets. The residual values ,useful life and method
of depreciation of property, plant and equipment
are reviewed annually and adjusted prospectively,
if appropriate.

The carrying amount of an asset is written down
immediately to its recoverable amount if the carrying
amount of the asset is greater than its estimated
recoverable amount.

Land accounted under finance lease is amortised on
a straight-line basis over the primary period of lease.

Derecognition of assets

An item of property plant & equipment and any
significant part initially recognised is derecognised
upon disposal or when no future economic benefits
are expected from its use or disposal. Any gain or
loss arising on derecognition of the asset is included
in the statement of profit and loss when the asset
is derecognised.

1.10 Financial instruments

Initial recognition

The company recognise the financial asset and financial
liabilities when it becomes a party to the contractual
provisions of the instruments. All the financial assets and
financial liabilities are recognised at fair value on initial
recognition, except for trade receivable which are initially
recognised at transaction price. Transaction cost that are
directly attributable to the acquisition of financial asset and
financial liabilities, that are not at fair value through profit
and loss, are added to the fair value on the initial recognition.

Subsequent measurement

(A) Non derivative financial instruments

(i) Financial Assets at amortised cost

A financial assets is measured at the amortised
cost if both the following conditions are met :

a) The asset is held within a business model
whose objective is to hold assets for collecting
contractual cash flows, and

b) Contractual terms of the asset give rise on
specified dates to cash flows that are solely
payments of principal and interest (SPPI) on the
principal amount outstanding.

This category is the most relevant to the
Company. All the Loans and other receivables
under financial assets (except Investments) are
non-derivative financial assets with fixed or
determinable payments that are not quoted
in an active market. Trade receivables do not
carry any interest and are stated at their nominal
value as reduced by impairment amount.

(ii) Financial Assets at Fair Value through
Profit or Loss/Other comprehensive
income

Instruments included within the FVTPL category
are measured at fair value with all changes
recognised in the Statement of Profit and Loss.

If the company decides to classify an instrument
as at FVTOCI, then all fair value changes on the
instrument, excluding dividends, are recognised
in the OCI. There is no recycling of the amounts
from OCI to P&L, even on sale of investment.
However, the company may transfer the
cumulative gain or loss within equity.

(iii) Financial liabilities

The measurement of financial liabilities depends
on their classification, as described below:

(a) Loans and borrowings

Borrowings are initially recognised at fair value,
net of transaction costs incurred. Borrowings
are subsequently measured at amortised cost.
Any difference between the proceeds (net of
transaction costs) and the redemption amount is
recognised in profit or loss over the period of the
borrowings using the effective interest method.
Fees paid on the establishment of loan facilities
are recognised as transaction costs of the loan
to the extent that it is probable that some or all
of the facility will be drawn down. If not, the fee
is deferred until the draw down occurs.

Borrowings are removed from the Standalone
Balance Sheet when the obligation specified
in the contract is discharged, cancelled or
expired. The difference between the carrying
amount of a financial liability that has been
extinguished or transferred to another party
and the consideration paid, including any non¬
cash assets transferred or liabilities assumed, is
recognised in profit or loss as other income |
(expense).

Borrowings are classified as current liabilities
unless the Company has an unconditional right
to defer settlement of the liability for at least 12
months after the reporting period.

(b) Trade & other payables

Af ter initial recognition, trade and other
payables maturing within one year from the
Balance sheet date, the carrying amounts
approximate fair value due to the short maturity
of these instruments.

(B) Derivative financial instruments

The company holds derivatives financial instruments
such as foreign exchange forward and option
contracts to mitigate the risk of changes in exchange
rates on foreign currency exposures. Company has
taken all the forward contract from the bank.

The company have derivative financial
assets/financial liabilities which are not
designated as hedges;

Derivatives not designated are initially recognised
at the fair value and attributable transaction cost
are recognised in statement of profit and loss, when
incurred. Subsequent to initial recognition, these
derivatives are measured at fair value through

profit and loss. Asset/Liabilities in this category are
presented as current asset/current liabilities.

Derecognition

A financial liability is derecognised when the
obligation under the liability is discharged or
cancelled or expires. When an existing financial
liability is replaced by another from the same lender on
substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange
or modification is treated as the derecognition of the
original liability and the recognition of a new liability.
The difference in the respective carrying amounts is
recognised in the statement of profit or loss.

1.11 Borrowing costs

Borrowing costs directly attributable to the acquisition,
construction or production of an asset that necessarily takes
a substantial period of time to get ready for its intended use
or sale are capitalised as part of the cost of the asset. All
other borrowing costs are expensed in the period in which
they occur. Borrowing costs consist of interest and other
costs that an entity incurs in connection with the borrowing of
funds. Borrowing cost also includes exchange differences to
the extent regarded as an adjustment to the borrowing costs.
Other borrowing costs are expensed in the period in which
they are incurred.

1.12 Cash and cash equivalents

Cash and cash equivalent in the balance sheet comprise
cash at banks and on hand and short-term deposits which
are subject to an insignificant risk of changes in value.

For the purpose of the statement of cash flows, cash and
cash equivalents consist of cash and short-term deposits,
as defined above, as they are considered an integral part
of the Company's cash management.

1.13 Employee Benefits

i) Defined contribution plans (Provident
Fund)

In accordance with Indian Law, eligible employees
receive benefits from Provident Fund, which is defined
contribution plan. Both the employee and employer
make monthly contributions to the plan, which is
administrated by the Government authorities, each
equal to the specific percentage of employee's basic
salary. The Company has no further obligation under
the plan beyond its monthly contributions. Obligation
for contributions to the plan is recognised as an
employee benefit expense in the Statement of Profit
and Loss when incurred.

ii) Defined benefit plans (Gratuity)

Gratuity liability is a defined benefit obligation and is
computed on the basis of an actuarial valuation by an

actuary appointed for the purpose as per projected
unit credit method at the end of each financial year.
The liability or asset recognised in the Standalone
Balance Sheet in respect of defined benefit gratuity
plans is the present value of the defined benefit
obligation at the end of the reporting period less the
fair value of plan assets. The liability so provided is
paid to a trust administered by the Company, which
in turn invests in eligible securities to meet the liability
as and when it becomes due for payment in future.
Any shortfall in the value of assets over the defined
benefit obligation is recognised as a liability with a
corresponding charge to the Standalone Statement
of Profit and Loss.

The present value of the defined benefit obligation
is determined by discounting the estimated future
cash outflows with reference to market yields at the
end of the reporting period on government bonds
that have terms approximating to the terms of the
related obligation.

The net interest cost is calculated by applying the
discount rate at the beginning of the period to the net
balance of the defined benefit obligation and the fair
value of plan assets. This cost is included in employee
benefit expense in the Standalone Statement of Profit
and Loss.

Remeasurement gains and losses arising from
experience adjustments and changes in actuarial
assumptions are recognised in the period in which
they occur directly in other comprehensive income.
They are included in retained earnings in the
Statement of changes in equity and in the Standalone
Balance Sheet.

Changes in the present value of the defined benefit
obligation resulting from plan amendments or
curtailments are recognised immediately in profit or
loss as past service cost.

The Company recognises all Remeasurement of
net defined benefit liability/asset directly in other
comprehensive income and presented within equity.

iii) Short term benefits

Short term employee benefit obligations are measured
on an undiscounted basis and are expensed as a
related service provided. A liability is recognised
for the amount expected to be paid under short term
cash bonus or profit sharing plans if the Company
has a present legal or constructive obligation to
pay this amount as a result of past service provided
by the employee and the obligation can be
estimated reliably.

1.14 Lease

The Company assesses whether a contract is, or contains a

lease, at inception of the contract. A contract is, or contains,

a lease if the contract conveys the right to control the use
of an identified asset for a period of time in exchange for
consideration. To assess whether a contract conveys the
right to control the use of an identified asset, the Company
assesses whether: i) the contract involves the use of an
identified asset, ii) the Company has substantially all of the
economic benefits from use of the asset through the period
of the lease and iii) the Company has the right to direct the
use of the asset.

At the commencement date of the lease, the Company
recognises a right-of-use asset and a corresponding lease
liability for all lease arrangements in which it is a lessee,
except for short-term leases (leases with a term of twelve
months or less), leases of low value assets and, for contract
where the lessee and lessor has the right to terminate a lease
without permission from the other party with no more than
an insignificant penalty. The lease expense of such short¬
term leases, low value assets leases and cancellable leases,
are recognised as an operating expense on a straight-line
basis over the term of the lease.

At the commencement date, lease liability is measured at the
present value of the lease payments to be paid during the
non-cancellable period of the contract, discounted using
the incremental borrowing rate. The right-of-use assets is
initially recognised at the amount of the initial measurement
of the corresponding lease liability, lease payments made
at or before commencement date less any lease incentives
received and any initial direct costs.

Subsequently, the right-of-use asset is measured at cost
less accumulated depreciation and any impairment losses.
Lease liability is subsequently measured by increasing the
carrying amount to reflect interest on the lease liability
(using effective interest rate method) and reducing the
carrying amount to reflect the lease payments made. The
right-of-use asset and lease liability are also adjusted to
reflect any lease modifications or revised in-substance fixed
lease payments.

1.15Earnings per share

Basic and diluted earnings per share are computed by
dividing the net profit attributable to equity shareholders for
the year, by the weighted average number of equity shares
outstanding during the year.

1.16 Research and Development
expenditure

Expenditure on research is recognised as an expense
when it is incurred. Expenditure on development which
does not meet the criteria for recognition as an intangible
assets is recognised as an expense when it is incurred.
Items of Property, Plant and Equipment and acquired
Intangible assets are used for research and development
are capitalised and depreciated in accordance with the
policies stated for Property, Plant and Equipment and
Intangible assets.

Shareholders of the Company vide its resolution dated March 26, 2025 approved the sub-division/ split of 1 (One) Equity Share of the
Company of the face value of I 10/- (Rupees Ten Only) each fully paid up, into 2 (Two) Equity Shares of the Company of face value of
I 5/- (Rupee Five Only) each fully paid up. Accordingly, w.e.f March 26, 2025 the Authorised share capital stood as I 50,00,00,000 divided
into 10,00,00,000 equity shares of I 5 each. The Issued, subscribed and paid up capital stood at I 40,93,44,610 divided into 8,18,68,922
equity shares of I 5 each. The process of credit of the sub-divided shares arising out of the split/sub-division got effected from the record
date of April 25, 2025 fixed for the purpose.

The Company has only one class of equity shares. Each holder of equity shares is entitled to one vote per share. The dividend proposed, if
any by the Board of Directors is subject to approval of the shareholders.

In the event of liquidation of the Company, the holders of the equity shares will be entitled to receive remaining assets of the Company, after
distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

17a Information regarding issue of shares in the last five years

The Company has not issued any shares without payment being received in cash.

Equity shares issued as bonus shares

2,10,00,000/- equity shares of I 10 each as fully paid bonus shares in the ratio of two (2) Equity Shares for each Equity Share held by
a shareholder (FY2021)

IPO

32,78,688/- equity shares of I 10 each as fully at a price of RS. 610/- per share (FY 2022)

Preferential allotment

16,58,374/- equity shares of I 10 each as fully at a price of RS. 603/- per share (FY 2022)

4,43,500/- equity shares of I 10 each as fully at a price of RS. 1,169/- per share (FY2024)

7,99,193/- equity shares of I 10 each as fully at a price of RS. 1,240/- per share (FY2025)

Qualified Institutional Placement

32,25,806/- equity shares of I 10 each as fully at a price of RS. 1,240/- per share ( FY 2025)

Issue of shares by way of ESOP (Refer note below)

28,900/- equity shares of I 10 each (FY 2025)

2,200/- equity shares of I 5 each (FY 2026)

17b Employee Stock Option Plan (ESOP)

During the FY 2022-23 the Company introduced share based incentives to eligible employees of the company under Employee Stock
Option Scheme ("ESOS 2023"). Whereby maximum number of shares under plan shall not exceed 3,64,370 (Three Lakh Sixty Four
Thousand Three Hundred and Seventy) equity share, subject to adjustments if any, as a result of corporate actions. Consequent to the
corporate action of split/sub-divion of shares the Nomination and Remunertaion Committee at its meeting held on July 30, 2025 adjusted
the total 3,34,370 options available for grant to 6,68,740 options. The options would vest on time based as well as achievement of
defined performance parameters as determined by Board/ Nomination and Remuneration committee. The performance parameters
are based on operating performance metrics of the employees as decided by Board/ Nomination and Remuneration committee. Each
of the performance parameters will be distinct for the purpose of calculation of the quantity of the shares to vest based on performance.
The instruments generally vests within one years from grant date. Each option carries with a right to purchase one equity share of the
Company at exercise price determined by Nomination and Remuneration committee at the time of grant. During the year the NRC at its
meeting held on December 22, 2025 granted 3,25,009 options at an Excercise Price of 1 305/- per option to the eligible employees
of the Company which shall vest over four consecutive years from the date of Grant.

Company implemented the Category I Grant under the ESOS 2023 under which 30,000 options were granted at 100.00/- (face
value 110/- each) based on the recommendation of Nomination and Remuneration Committee. Under Category II Grants Company
has granted 3,25,009 options granted 3,25,009 options at an Excercise Price of 1 305/- per option to the eligible employees of the
Company which shall vest over four consecutive years from the date of Grant.

Shareholders of the Company vide its resolution dated March 26, 2025 approved the sub-division/ split of 1 (One) Equity Share
of the Company of the face value of 1 10/- (Rupees Ten Only) each fully paid up, into 2 (Two) Equity Shares of the Company of
face value of 1 5/- (Rupee Five Only) each fully paid up. The record date for the said sub-division was April 25, 2025. Accordingly
ESOP pool (maximum number of options available for grant under Category II of ESOS 2023 has been adjusted in the ratio 1:2
i.e from 3,34,370 to 6,68,740 options convertible into equal number of Equity shares on vesting and the Exercise Price for all
options to be granted under ESOS 2023 was accordingly revised from minimum 1 10/- to maximum 1 610/-, to minimum 1 5/- to
maximum 1 305/- per options, to be granted under Category II of ESOS 2023.

The options granted by NRC under Category II Grants of ESOS 2023 consist of both time based and performance based vesting
component i.e 60 % of the options granted and vesting annually will be Time based and 40% of the options granted and vesting
annually shall be performance based.

c) Fair Value on the grant date

The amount of maximum exposure to credit risk as at March 31, 2026 without taking account of any collateral or other credit
enhancements is as stated in table below:

The fair value at grant date is determined using Black Scholes Model which takes into account the exercise price, the term of the
option, the share price at grant date and expected price volatility of the underlying share, the expected dividend yield and the
risk free interest rate for the term of the option.

Purpose of Reserve stated as follows:

Securities premium: Securities premium is used to record the premium on issue of shares. The reserve to be utilized in accordance with
the provisions of the Companies Act, 2013.

Capital reserve: Capital reserve that indicates the cash on hand that can be used for future expenses or to offset any capital losses.It is
derived from the accumulated capital surplus of a company and is created out of its profit.

Retained earnings: Retained earnings represents undistributed profits of the Company which can be distributed to its equity shareholders
in accordance with the provisions of the Companies Act, 2013.

Employees stock option reserve: The fair value of the equity-settled share-based payment transactions is recognized in statement of
profit and loss with corresponding credit to Employees stock option reserve.

38 Defined Benefit Plans

The Company has a funded defined benefit gratuity plan. The gratuity plan is governed by the Payment of Gratuity Act, 1972. Under the
Act, employee who has completed five years of service is entitled to specific benefit. The level of benefits provided depends on the member's
length of service and salary at retirement age. Every employee who has completed five years or more of service gets a gratuity on departure
at 15 days salary (last drawn salary) for each completed year of service as per the provision of the Payment of Gratuity Act, 1972 with total
ceiling on gratuity of 120,00,000.

42 Segment Reporting
Business Segment

In accordance with IND AS 108 "Operating segment" - The Company used to present the segment information identified on the basis of internal
report used by the Company to allocate resources to the segment and assess their performance. The Board of Directors of the Company is
collectively the Chief Operating Decision Maker (CODM) of the Company.

The chief operating decision maker monitors the operating results of its segment separately for the purpose of making decisions about resources
allocation and performance assessment. Segment performance is evaluated on the basis on profit and loss.

(ii) Related Party Transactions

The related party relationships have been determined on the basis of the requirements of the Indian Accounting Standard (Ind AS) -24
'Related Party Disclosures' and the same have been relied upon by the auditors.

The relationships as mentioned above pertain to those related parties with whom transactions have taken place during the current year
/previous year, except where control exists, in which case the relationships have been mentioned irrespective of transactions with the
related party.

Fair Value Hierarchy

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices)
or indirectly (i.e. derived from prices).

Level 3 - Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).

There have been no transfers among Level 1, Level 2 and Level 3 during the period.

The management assessed that cash and cash equivalents, Trade receivable and other financial asset, trade payables and other financial
liabilities approximate their carrying amount largely due to short term maturity of these instruments.

Financial Risk Management - Objectives and Policies

The risk management policies of the Company are established to identify and analyse the risks faced by the Company, to set appropriate
risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to
reflect changes in market conditions and the Company's activities.

The Management has overall responsibility for the establishment and oversight of the Company's risk management framework.

In performing its operating, investing and financing activities, the Company is exposed to the Credit risk, Liquidity risk and Market risk.

Carrying Amount of Financial Assets and Liabilities:

The following table summaries the carrying amount of financial assets and liabilities recorded at the end of the period by categories:

B. Market Risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices.
Market risk comprises three types of risk: interest rate risk, currency risk and other price risk, such as equity price risk and commodity
risk. Financial instruments affected by market risk include loans and borrowings, deposits and derivative financial instruments.

a. Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates.

Company has interest rate risk exposure mainly from changes in rate of interest on borrowing & on deposit with bank. The interest
rate are disclosed in the respective notes to the financial statements of the Company. The following table analyse the breakdown
of the financial assets and liabilities by type of interest rate:

(ii) Sensitivity Analysis

The following table demonstrates the sensitivity to a reasonably possible change in interest rates on that portion of loans and
borrowings affected, after the excluding the credit exposure for which interest rate swap has been taken and hence the interest
rate is fixed. With all other variables held constant, the Company's profit before tax is affected through the impact on floating
rate borrowings, as follows:

b. Foreign Currency Risk

The Company operates internationally and the major portion of business is transacted in USD & EURO. The Company has Sales,
Purchase, (etc.) in foreign currency. Consequently, the Company is exposed to foreign exchange risk.

Foreign exchange exposure is partially balanced by purchasing in goods, commodities and services in the respective currencies.

The company evaluate exchange rate exposure arising from foreign currency transactions and the company follows established
risk management policies, including the use of derivatives like foreign exchange forward contracts to hedge exposure to foreign
currency risk.

Foreign currency exposures not specifically covered by natural hedge and forward exchange contracts as at year end are
as follows:

C. Credit Risk

Financial assets that are potentially subject to concentrations of credit risk and failures by counterparties to discharge their
obligations in full or in a timely manner consist principally of cash balances with banks, cash equivalents and receivables, and other
financial assets. The maximum exposure to credit risk is: the total of the fair value of the financial instruments and the full amount
of any loan payable commitment at the end of the reporting year. Credit risk on cash balances with banks is limited because the
counterparties are entities with acceptable credit ratings. Credit risk on other financial assets is limited because the other parties
are entities with acceptable credit ratings.

As disclosed in Note 12, cash and cash equivalents balances generally represent short term deposits with a less than 90-
day maturity.

As part of the process of setting customer credit limits, different credit terms are used. The average credit period generally granted
to trade receivable customers is about 90-360 days. But some customers take a longer period to settle the amounts.

D. Liquidity Risk

Liquidity risk is the risk that the Company may not be able to meet its present and future cash and collateral obligations without
incurring unacceptable losses. The Company's objective is to, at all times maintain optimum levels of liquidity to meet its cash
and collateral requirements. The Company closely monitors its liquidity position and deploys a robust cash management system.
It maintains adequate sources of financing including debt and overdraft from banks at an optimised cost.

The Company maximum exposure to credit risk for the components of the balance sheet at March 31 2026 and March 31 2025 is
the carrying amounts. The liquidity risk is managed on the basis of expected maturity dates of the financial liabilities. The average
credit period taken to settle trade payables is about 90 days. The other payables are with short-term durations. The carrying
amounts are assumed to be a reasonable approximation of fair value. The following table analysis financial liabilities by remaining
contractual maturities:

E. Capital Management

For the purpose of the Company's capital management, capital includes issued equity capital, share premium and all other
equity reserves attributable to the equity holders of the parent. The primary objective of the Company's capital management is
to maximise the shareholder value.

The Company manages its capital structure and makes adjustments in light of changes in economic conditions and the requirements
of the financial covenants. To maintain or adjust the capital structure, the Company may adjust the dividend payment to
shareholders, return capital to shareholders or issue new shares. The Company monitors capital using a gearing ratio, which is
net debt divided by total capital plus net debt. The Company's policy is to keep optimum gearing ratio. The Company includes
within net debt, interest bearing loans and borrowings, trade and other payables, less cash and cash equivalents, excluding
discontinued operations.

Note:

In order to achieve this overall objective, the Company's capital management, amongst other things, aims to ensure that it meets financial covenants
attached to the interest-bearing loans and borrowings that define capital structure requirements. Breaches in meeting the financial covenants
would permit the bank to immediately call loans and borrowings. There have been no breaches in the financial covenants of any interest-bearing
loans and borrowing in the current period.

46 Compa ny has filled all charges within due dates with ROC.

47 Dividends

The Code on Social Security, 2020 was formally enacted on September 28, 2020 and its core provisions were brought into full operational
force by the Ministry of Labour & Employment vide notification issued on November 21, 2025. The Company has assessed the impact in its
financial statements the during the period of review and has reported no material financial impact due to the Code becoming effective w.e.f
November 21, 2025

48 Dividends

During the year, the Company has paid a Final dividend of I 1.50 per share in respect of the year ended March 31, 2025 which was proposed
by the Board of Directors on May 02, 2025, and was subsequently approved by the shareholders at the Annual General Meeting, held on
Sep 25, 2025, which has resulted in a cash outflow of I 1228.03 Lakh. Dividends are declared based on profits available for the distribution.

51 Additional regulatory information
required by Schedule III

(i) Details of benami property held

No proceedings have been initiated or pending against the
company under the Benami Transactions (Prohibition) Act,
1988 (45 of 1988) and the rules made thereunder.

(ii) Willful defaulter

The Company is not declared willful defaulter by any
bank or financial Institution or government or any
government authority.

(iii) Borrowings secured against current

assets

The Company having Working capital loans repayable on
demand from banks is unsecured.

(iv) Relationship with struck off companies

The Company has no transactions with companies struck off
under section 248 of the Companies Act, 2013 or section
560 of Companies Act, 1956.

(v) Compliance with number of layers of
companies

The Company has complied with the number of layers
prescribed under clause (87) of section 2 of the Act read
with the Companies (Restriction on number of Layers)
Rules, 2017.

(vi) Compliance with approved scheme(s)
of arrangements

The Company has not entered into any scheme of
arrangement which has an accounting impact on current or
previous financial period/year.

(vii) Utilisation of borrowed funds and
share premium

The Company has not advanced or loaned or invested
funds (either borrowed funds or share premium or any
other sources or kind of funds) to any other person(s) or
entity(ies), including foreign entities (Intermediaries) with the
understanding (whether recorded in writing or otherwise)
that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or
entities identified in any manner whatsoever by or on behalf
of the company (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf
of the Ultimate Beneficiaries.

The Company has not received any fund from any person(s)
or entity(ies), including foreign entities (Funding Party)
with the understanding (whether recorded in writing or
otherwise) that the company shall:

(a) directly or indirectly lend or invest in other persons or
entities identified in any manner whatsoever by or on behalf
of the Funding Party (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of
the Ultimate Beneficiaries.

(viii) Undisclosed income

There is no income surrendered or disclosed as income
during the current or previous period/year in the tax
assessments under the Income Tax Act, 1961, that has not
been recorded in the books of account.

(ix) Details of crypto currency or virtual
currency

The Company has not traded or invested in Crypto currency
or Virtual Currency during the financial period/year.

(x) Valuation of PPE, intangible asset and
investment property

The Company has not revalued its Property, Plant and
Equipment (including Right-of-Use Assets) or intangible
assets or both during the current or previous year.

(xi) Title deeds of immovable properties
not held in name of the company

The title deeds of all the immovable property (other than
properties where the Company is the lessee and the lease
agreements are duly executed in favour of the lessee) are
held in the name of the company.

(xii) Registration of charges or satisfaction
with Registrar of Companies (ROC)

There are no charges or satisfaction which are yet to be
registered with ROC beyond the statutory period.

(xiii) Utilisation of borrowings availed from
bank and financial institutions

The Company has NIL outstanding secured borrowings
from banks.

52 The Ministry of Corporate Affairs (MCA) has prescribed a new
requirement for companies under the proviso to Rule 3(1) of the
Companies (Accounts) Rules, 2014 inserted by the Companies

(Accounts) Amendment Rules 2021 requiring companies, which
use accounting software for maintaining its books of accounts,
to use only such accounting software which has a feature of
recording audit trail of each and every transaction, creating an
edit log of each change made in the books of account along with
the date when such changes were made and ensuring that the
audit trail cannot be disabled.

During the year ended March 31 2026, the audit trail feature was
enabled both at the application level and data base level in the
accounting software used bythe Company to maintain its books
of accounts.

53 Subsequent Events

The Company has evaluated subsequent events up to the date of
approval of these financial statements and no such events have
occurred that require adjustment or disclosure. No adjusting or
non-adjusting events have occurred after the reporting period that
require disclosure under Ind AS 10.

54 As of the balance sheet date, there are contracts amounting to I
16,141.26/- lakhs that remain to be executed and have not yet
been provided for. An advance of I 2,940.47/- lakhs has been
paid for these contracts.

55 In the opinion of the management, current assets, loans, advances
and deposits are approximately of the value stated, if realised in
the ordinary course of business and are subject to confirmation.

56 Balances in the accounts of Trade Receivables, Loans and
Advances, Trade Payables and Other Current Liabilities are
subject to confirmation / reconciliation, if any. The management
does not expect any material adjustment in respect of the
same effecting the financial statements on such reconciliation
/ adjustments.

The estimates at March 31, 2026 and March 31, 2025 are
consistent with those made for the same dates in accordance with

Ind As(after adjustments to reflect any differences in accounting
policies).

57 There was no impairment loss on the fixed assets on the basis of
review carried out by the management in accordance with Indian
Accounting Standard (Ind AS)-36 'Impairment of Assets.

58 The tax rate used for the reconciliation above is the corporate
tax rate payable by corporate entities in India on taxable profits
under the Indian tax law.

The Company has elected to exercise the option permitted under
Section 115BAA of the Income-tax Act, 1961 as introduced by
the Taxation Laws (Amendment) Ordinance, 2019 which gives a
one time irreversible option to domestic companies for payment
of corporate tax at reduced rates. Accordingly, the Company has
re-measured its deferred tax asset (net) basis the rate prescribed
in the said section.

59 The Shareholders at their Extra-ordinary General Meeting held on
meeting held on May 10, 2025 approved the change in name of
the Company from "Ami Organics Limited" to "Acutaas Chemicals
Limited". The Ministry of Corporate Affairs, Office of the Central
Processing Unit approved the change in name and issued Fresh
Certificate of Incorporation on May 15, 2025. Accordingly,
the name of Company changed from "Ami Organics Limited" to
"Acutaas Chemicals Limited" w.e.f May 15, 2025.

60 Previous years figure have been regrouped/rearranged wherever
necessary, to correspond with the current year classification
/ disclosures.

61 The balance sheet, statement of profit and loss, cash flow
statement, statement of changes in equity, statement of material
accounting policies and the other explanatory notes forms an
integral part of the financial statements of the Company for the
year ended March 31, 2026.